DiscoverUnivadis Practice ChangersUnivadis Practice Changers: NOACs vs VKAs in Afib with early-stage CKD
Univadis Practice Changers: NOACs vs VKAs in Afib with early-stage CKD

Univadis Practice Changers: NOACs vs VKAs in Afib with early-stage CKD

Update: 2019-09-16
Share

Description

A recent meta-analysis shows a superior risk-benefit profile for NOACs over vitamin K antagonists in patients with Afib and early-stage CKD.

Comments 
In Channel
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Univadis Practice Changers: NOACs vs VKAs in Afib with early-stage CKD

Univadis Practice Changers: NOACs vs VKAs in Afib with early-stage CKD

Alissa Scott